RCAS1 antibody (AA 28-213)
Quick Overview for RCAS1 antibody (AA 28-213) (ABIN3023673)
Target
See all RCAS1 (EBAG9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 28-213
-
Sequence
- RSGRGRKLSG DQITLPTTVD YSSVPKQTDV EEWTSWDEDA PTSVKIEGGN GNVATQQNSL EQLEPDYFKD MTPTIRKTQK IVIKKREPLN FGIPDGSTGF SSRLAATQDL PFIHQSSELG DLDTWQENTN AWEEEEDAAW QAEEVLRQQK LADREKRAAE QQRKKMEKEA QRLMKKEQNK IGVKLS
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 28-213 of human EBAG9 (NP_004206.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))
-
Alternative Name
- EBAG9
-
Background
- This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10.,EBAG9,EB9,PDAF,Cancer,Tumor immunology,Tumor-associated antigens,Tumor biomarkers,Signal Transduction,Cell Biology & Developmental Biology,Apoptosis,Growth factor,Immunology & Inflammation,EBAG9
-
Molecular Weight
- 24 kDa/29 kDa
-
Gene ID
- 9166
-
UniProt
- O00559
Target
-